The redirection of healthcare and life sciences resources to COVID-19 has taken focus from other areas of need, including antimicrobial resistance.
Jamie Culp
Advertisement
Articles by Jamie Culp
Advertisement
Latest Updated Articles
COVID and AMR: Crisis Reframes Antibiotics FightDecember 11th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro
2
Hims & Hers Partners with Eli Lilly to Sell Obesity Medicines
3
What Does a Positive Reading for Leronlimab Mean for How the Industry Thinks About Repurposing Old Biologics Into Oncology?
4
The US Drug-Pricing Reset: Competing on Net Value
5